St Luke's Wood River Medical Center Critical Access Hospital (Medicare Certified) Location: 100 Hospital Drive, Ketchum, Idaho 83340 Ratings: Phone: (208) 727-8800 |
News Archive
GlaxoSmithKline and A*STAR's Institute of Chemical and Engineering Sciences have signed a five-year strategic agreement to develop new evidence based formulations specifically for emerging markets.
In this Business Day opinion piece, Donald Gips, the U.S. ambassador to South Africa, examines progress made in the country's fight against HIV/AIDS, writing that, through the coordination of governments, civil society, nongovernmental organizations (NGOs), educational institutions, and researchers from around the world, "we now have the tools that allow us for the first time to set the goal of achieving an AIDS-free generation - when virtually no children are born with the virus; we have effective and comprehensive education and prevention strategies that help to reduce risk; and those who are infected with HIV have access to treatment that helps prevent them from developing AIDS and transmitting the virus."
Eli Lilly and Company announced today that it has suspended its global Phase III study evaluating tasisulam, an investigational, small-molecule anti-cancer compound, as a second-line treatment for those with unresectable or metastatic melanoma.
A targeted therapy drug used for breast and kidney cancers may also extend progression-free survival for patients with advanced head and neck cancer who are at high risk for recurrence after standard treatment.
› Verified 2 days ago